Survey Shows Few Adults Recognize Testicular Cancer as Affecting Young Men
By Lori Solomon HealthDay Reporter
FRIDAY, June 27, 2025 -- Only one in 10 U.S. adults correctly identified testicular cancer as most commonly affecting men under age 40, according to a survey released June16 by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).
The survey included 1,008 respondents aged ≥18 years. Results showed that only 13 percent of participants correctly identified testicular cancer as most commonly affecting men under age 40. Six in 10 respondents (63 percent) correctly identified that testicular cancer is often curable if caught early, while just over half (54 percent) correctly said that monthly self-checks should be conducted. Younger adults (aged 18 to 29 years) were more likely than all other age groups to incorrectly agree with the statement that testicular cancer symptoms are always painful (18 percent).
"Testicular cancer does not typically come with painful symptoms," Shawn Dason, M.D., from OSUCCC—James, said in a statement. "That’s why routine self-exams are so important to detect any lumps or changes to the testicle. If you feel something out of the ordinary, like a lump or bump, or if the testicle changes in size, call your doctor."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
32 Percent of U.S. Adults Consumed Fast Food on a Given Day in 2021 to 2023
FRIDAY, June 27, 2025 -- Over 30 percent of adults and children consumed fast food on a given day during August 2021 to August 2023, according to two reports from the National...
Disparities Seen in Continuous Glucose Monitor Rx by Language Preference
FRIDAY, June 27, 2025 -- For patients with type 2 diabetes (T2D), disparities in continuous glucose monitor (CGM) prescriptions are seen by language preference, with less access...
Genetic Testing for Developmental Disabilities Low Among Children Enrolled in Medicaid
FRIDAY, June 27, 2025 -- Clinical implementation of genetic testing in children with neurodevelopmental disabilities in the Medicaid-enrolled population remains low, according to...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.